Remove Development Remove Doctors Remove Hormones Remove Research
article thumbnail

Get Involved in Understanding Your Brain and Genes

Trialfacts

Findings from this study may assist in the development of improved diagnosis, early intervention, and treatment. You will be helping researchers to better understand how to identify people at risk of psychiatric disorders. You will be helping researchers to potentially improve early detection and diagnosis of psychiatric disorders.

Gene 52
article thumbnail

FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer

The Pharma Data

FDA Approves Orgovyx (relugolix) as the First Oral Gonadotropin-Releasing Hormone (GnRH) Receptor Antagonist for Advanced Prostate Cancer. Orgovyx, which was granted Priority Review by the FDA, is the first and only oral gonadotropin-releasing hormone (GnRH) receptor antagonist for men with advanced prostate cancer.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Could Mom’s Thyroid Levels Influence ADHD in Kids?

The Pharma Data

21, 2020 — Low levels of thyroid hormone during pregnancy may contribute to the development of attention deficit hyperactivity disorder in the child, new research suggests. children, according to the researchers. Many of those genes are regulated by thyroid hormones, the team noted. WEDNESDAY, Oct.

article thumbnail

Genetic biomarkers could personalise therapy for TNBC

Drug Discovery World

The study, by researchers at The Institute of Cancer Research, London, shows that certain characteristics within patients’ primary tumours can predict how they will respond to different treatments after their tumours have spread around the body.

article thumbnail

Skincare Routines for People with Hidradenitis Suppurativa

Olympian Clinical Research

While the exact cause is unknown, factors like genetics, inflammation, and hormones play a role. Here are some common triggers of HS: Hormonal Changes: Many individuals with HS report flare-ups during periods of hormonal change, such as menstruation, pregnancy, or menopause.

article thumbnail

Nitric oxide could form treatment approach for breast cancer

Drug Discovery World

A new therapeutic approach for triple negative breast cancer using nitric oxide is being explored by researchers at the medical research centre CÚRAM. Triple-negative breast cancer is invasive breast cancer that does not respond to hormonal therapy medicines or the current medicines that target the HER2 protein.

article thumbnail

What are the Symptoms of Prurigo Nodularis?

Olympian Clinical Research

Prurigo nodularis is a skin condition characterized by the development of small nodular lesions, which are often severely itchy. People afflicted with this disease may develop a few lesions or potentially over 200, all of which with varying sizes. Excessive itching may also cause infections to develop. . Thyroid hormone panel.